Cardinal Health (CAH) Stock Forecast & Price Target

$147.36 +1.32 (+0.91%)

As of 03:48 PM Eastern

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
3

Buy
12

Based on 15 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 3 have given a hold rating, and 12 have given a buy rating for CAH.

Consensus Price Target

$165.93
12.60% Upside

According to the 15 analysts' twelve-month price targets for Cardinal Health, the average price target is $165.93. The highest price target for CAH is $203.00, while the lowest price target for CAH is $124.00. The average price target represents a forecasted upside of 12.60% from the current price of $147.36.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

CAH Analyst Ratings Over Time

Type	Current Forecast 8/26/24 to 8/26/25	1 Month Ago 7/27/24 to 7/27/25	3 Months Ago 5/28/24 to 5/28/25	1 Year Ago 8/27/23 to 8/26/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)	7 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$165.93	$158.07	$146.43	$118.45
Forecasted Upside	12.60% Upside	0.62% Upside	-4.32% Downside	8.07% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Medical Companies	S&P 500
Consensus Rating Score	2.80	2.79	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	12.46% Upside	14,112.70% Upside	10.60% Upside
News Sentiment Rating	Positive News See Recent CAH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/22/2025	Argus 4 of 5 stars		Set Target		$189.00	+28.15%
8/13/2025	Wells Fargo & Company 3 of 5 stars	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$183.00 ➝ $185.00	+26.27%
8/13/2025	Evercore ISI 3 of 5 stars	Elizabeth Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$200.00 ➝ $190.00	+29.68%
8/13/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Coldwell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$197.00 ➝ $203.00	+38.56%
8/12/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Tanquilut Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$150.00	-5.10%
8/12/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
8/12/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
8/12/2025	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$188.00 ➝ $186.00	+26.95%
6/13/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Grosslight Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$157.00 ➝ $170.00	+5.97%
6/10/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$165.00 ➝ $170.00	+10.65%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
3/31/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Valiquette Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$142.00 ➝ $150.00	+9.95%
2/4/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$142.00 ➝ $145.00	+13.97%
1/8/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Rhyee Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$130.00 ➝ $144.00	+18.90%
11/4/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$119.00 ➝ $124.00	+9.48%
11/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$117.00 ➝ $133.00	+14.53%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:48 PM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 25, 2025. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

The company has a strong dividend yield of approximately 1.4%, which can provide a steady income stream for investors.
Recent analyst ratings indicate a consensus of "Moderate Buy," suggesting positive sentiment among investment professionals.
Cardinal Health, Inc. has a solid earnings forecast, with analysts predicting earnings per share of around 7.95 for the current year, indicating potential growth.
Institutional ownership is high at 87.17%, reflecting confidence from large investors in the company's stability and growth prospects.
The current stock price is around $163.20, which is considered attractive given the company's growth potential and recent positive analyst ratings.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

Despite a strong dividend, the company's payout ratio is 31.63%, which may limit future dividend increases if earnings do not grow as expected.
Some analysts have recently lowered their price targets for the stock, indicating potential concerns about future performance.
Market volatility and economic uncertainties could impact the healthcare sector, affecting Cardinal Health, Inc.'s performance.
There is competition in the healthcare services market, which could pressure margins and growth opportunities for Cardinal Health, Inc.
Recent changes in analyst ratings show mixed sentiments, with some downgrades that could signal caution for potential investors.

CAH Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $165.93, with a high forecast of $203.00 and a low forecast of $124.00.
: 15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 3 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CAH shares.
: According to analysts, Cardinal Health's stock has a predicted upside of 12.60% based on their 12-month stock forecasts.
: Over the previous 90 days, Cardinal Health's stock had 1 upgrade by analysts.
: Cardinal Health has been rated by research analysts at Argus, Bank of America, Citigroup, Evercore ISI, Jefferies Financial Group, Leerink Partners, Morgan Stanley, Robert W. Baird, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Cardinal Health more than other "medical" companies. The consensus rating score for Cardinal Health is 2.80 while the average consensus rating score for "medical" companies is 2.79. Learn more on how CAH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CAH) was last updated on 8/26/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Stock Forecast & Price Target